S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 22 of 22

Issue Date	Title / Author(s) / Citation	File
2005-06	Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers Chung, Jae-Yong; Cho, Joo-Youn; Yu, Kyung-Sang; Kim, Jung-Ryul; Jung, Hye-Ryung; Lim, Kyoung-Soo; Jang, In-Jin; Shin, Sang-Goo Clin Pharmacol Ther. 2005 Jun;77(6):486-94.	link
2005-10	Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers Chung, Jae-Yong; Cho, Joo-Youn; Yu, Kyung-Sang; Kim, Jung-Ryul; Oh, Dal-Seok; Jung, Hye-Ryung; Lim, Kyoung-Soo; Moon, Ki-Ho; Shin, Sang-Goo; Jang, In-Jin Clin Pharmacol Ther. 2005 Oct;78(4):342-50.	link
2006-06	Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel Suh, Jung-Won; Koo, Bon-Kwon; Zhang, Shu-Ying; Park, Kyung-Woo; Cho, Joo-Youn; Jang, In-Jin; Lee, Dong-Soon; Sohn, Dae-Won; Lee, Myoung-Mook; Kim, Hyo-Soo CMAJ 2006;174:1715-22	view file link
2006-06	Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel Suh, Jung-Won; Koo, Bon-Kwon; Zhang, Shu-Ying; Park, Kyung-Woo; Cho, Joo-Youn; Jang, In-Jin; Lee, Dong-Soon; Sohn, Dae-Won; Lee, Myoung-Mook; Kim, Hyo-Soo CMAJ. 2006 Jun 6;174(12):1715-22.	view file link
2006-09	Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study Kim, Euitae; Yu, Kyung-Sang; Cho, Joo-Youn; Shin, Yong-Wook; Yoo, So Young; Kim, Young Youn; Jang, In-Jin; Shin, Sang-Goo; Kwon, Jun Soo Hum Psychopharmacol. 2006 Dec;21(8):519-28.	link
2006-09	Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study Kim, Euitae; Yu, Kyung-Sang; Cho, Joo-Youn; Shin, Yong-Wook; Yoo, So Young; Kim, Young Youn; Jang, In-Jin; Shin, Sang-Goo; Kwon, Jun Soo Hum Psychopharmacol. 2006 Dec;21(8):519-28.	link
2006-12	Angiotensin II type 1 receptor 1166A/C polymorphism in association with blood pressure response to exogenous angiotensin II Lim, Hyeong-Seok; Cho, Joo-Youn; Oh, Dal-Seok; Chung, Jae-Yong; Hong, Kyoung-Sup; Bae, Kyun-Seop; Yu, Kyung-Sang; Lee, Kyung-Hoon; Jang, In-Jin; Shin, Sang-Goo Eur J Clin Pharmacol. 2007 Jan;63(1):17-26. Epub 2006 Dec 5.	link
2008-03	Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects Kim, Bo-Hyung; Lim, Hyeong-Seok; Chung, Jae-Yong; Kim, Jung-Ryul; Lim, Kyoung Soo; Sohn, Dong-Ryul; Cho, Joo-Youn; Yu, Kyung-Sang; Shin, Sang-Goo; Paick, Jae-Seung; Jang, In-Jin Br J Clin Pharmacol. 2008;65(6):848-854	link
2008-03	Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects Kim, Bo-Hyung; Lim, Hyeong-Seok; Chung, Jae-Yong; Kim, Jung-Ryul; Lim, Kyoung Soo; Sohn, Dong-Ryul; Cho, Joo-Youn; Yu, Kyung-Sang; Shin, Sang-Goo; Paick, Jae-Seung; Jang, In-Jin Br J Clin Pharmacol. 2008; 65(6): 848-854	link
2008-08	Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D610 allele in healthy Korean subjects Lim, Kyoung Soo; Cho, Joo-Youn; Jang, In-Jin; Kim, Bo-Hyung; Kim, JaeWoo; Jeon, Ji-Young; Tae, Yu-Mi; Yi, SoJeong; Eum, SoYoung; Shin, Sang-Goo; Yu, Kyung-Sang* Br J Clin Pharmacol. 2008; 66(5): 660-6	link
2008-11	Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study Lim, Kyoung Soo; Kim, Jung-Ryul; Choi, Yun-Jung; Shin, Kwang-Hee; Kim, Kyu-Pyo; Hong, Jang-Hee; Cho, Joo-Youn; Shin, Hyun-Suk; Yu, Kyung-Sang; Shin, Sang-Goo; Kwon, O Hwan; Hwang, Dal-Mi; Kim, Jeong-Ae; Jang, In-Jin Clin Ther. 2008;30(10):1817-1830	link
2008-11	Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients Kim, Jung-Ryul; Seo, Hyo-Bum; Cho, Joo-Youn; Kang, Do-Hyung; Kim, Yong Ku; Bahk, Won-Myong; Yu, Kyung-Sang; Shin, Sang-Goo; Kwon, Jun Soo; Jang, In-Jin Br J Clin Pharmacol. 2008 ;66(6):802-10.	link
2008-11	Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients Kim, Jung-Ryul; Seo, Hyo-Bum; Cho, Joo-Youn; Kang, Do-Hyung; Kim, Yong Ku; Bahk, Won-Myong; Yu, Kyung-Sang; Shin, Sang-Goo; Kwon, Jun Soo; Jang, In-Jin Br J Clin Pharmacol. 2008;66(6):802-10	link
2015-10	Rapid Hepatobiliary Excretion of Micelle-Encapsulated/Radiolabeled Upconverting Nanoparticles as an Integrated Form Seo, Hyo Jung; Nam, Sang Hwan; Im, Hyung-Jun; Park, Ji-Yong; Lee, Ji Youn; Yoo, Byeongjun; Lee, Yun-Sang; Jeong, Jae Min; Hyeon, Taeghwan; Kim, Ji Who; Lee, Jae Sung; Jang, In-Jin; Cho, Joo-Youn; Hwang, Do Won; Suh, Yung Doug; Lee, Dong Soo Scientific Reports, Vol.5, p. 15685	view file DOI
2017-02	Exploration of potential biomarkers for amoxicillin/clavulanate-induced liver injury in humans through multi-omics approaches Jieon Lee	view file
2020	Population pharmacokinetic analysis of amikacin for optimal pharmacotherapy in adult patients with nontuberculous mycobacterial pulmonary disease Jin Xuanyou	view file link
2022	Exploring the mechanism of the hypoglycemic effect of metformin mediated by the gut microbiota and endogenous metabolites 이유진	view file link
2022	Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-inflammatory Agent for COVID-19 Treatment 박예원	view file link
2023	Metabolomics study to explore pathophysiology and discover diagnostic biomarkers of idiopathic inflammatory myopathy 강지현	view file link
2023	Population pharmacokinetic analysis of two formulations of empagliflozin following a single oral dose in healthy adults 강욱	view file link
2023	Population PK/PD model to evaluate the effect of uremia on the pharmacokinetics of evogliptin 김병욱	view file link
2023	Plasma metabolomic signatures of nonalcoholic fatty liver disease and weight loss interventions in pediatric population with obesity 채우리	view file link